• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Manifest Learning Academy
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Society

Drug and Clinical trial rules 2019

April 3, 2019
in Society
Reading Time: 4 mins read
0
248
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook
image_pdfMake PDF

Manifest Pedagogy

Health has been a topic often in news more specifically the pharmaceutical industry. Issues like drug pricing, clinical trials, new authorities related to Homeopathy etc are highly relevant for this year

In news

Govt notifies new rules for drugs and clinical trials

Pacing it in the syllabus

Indian society: Health(not mentioned explicitly)

Indian Polity : Health

Static dimensions

Meaning of Clinical trials

Current dimensions

  • Drugs and Clinical trials Rules 2019 provisions
  • Importance of the rules

Content

What are clinical trials?

  • Clinical trials are research studies performed in individuals that are aimed at evaluating a medical, surgical, or behavioral intervention.
  • They are the essential way that scientists see whether another treatment, similar to another medication or diet or therapeutic gadget (for instance, a pacemaker) is protected and successful in individuals.
  • Frequently a clinical preliminary is utilized to learn if another treatment is progressively successful or potentially has less unsafe reactions than the standard treatment.

Drugs and Clinical TrialS Rules 2019

Aim

To promote clinical research in the country

Applicability of the rules

The new rules apply to:

  • All new drugs.
  • Investigational new drugs for human use,
  • Clinical trials.
  • Bio-equivalence studies and
  • Ethics committees.

Important provisions

    • The new rules will change the regulatory landscape for the approval of new drugs and conduct of clinical trials in the country.
    • Reduction in time for approval:The new rules reduced the time for approving applications to 30 days for manufactured in India and 90 days for those developed outside the country.
    • The rules mentioned that in case of no communication from Drugs Controller General of India, the application will be deemed to have been approved.
  • Waiving of trial: It is stated that the requirement of a local clinical trial may be waived for approval of a new drug if it is approved and marketed in any of the countries(EU, UK, Australia, Japan and US) to be specified by the Drugs Controller General with the approval of the government.
    • Patient safety: the new rules will ensure patient safety, as they would be enlisted for trials with informed consent.
  • Monitoring of trials: The ethics committee will monitor the trials and decide on the amount of compensation in cases of adverse events.
  • The compensation in cases of death and permanent disability or other injuries to a trial subject will be decided by the Drug Controller General.
  • Conditions for providing post-trial access of drugs to patients who require it have been defined for the first time. In a first, orphan drugs have been defined as a drug intended to treat conditions which affects not more than five lakh persons in India.

Importance of the rules

    • Benefit to the patients: As stated by Indian council of Clinical Research(ISCR) the new Clinical Trial Rules are well balanced and will further the conduct of ethical and quality clinical trials in the country which, in turn, will benefit patients.
    • Protect the rights and safety of patients: The new principles secure the rights, wellbeing of patients while guaranteeing a solid scientific base for the lead of clinical trials.
  • Boost for clinical research: experts hope that the rules will help to maintain stability and growth in clinical research being done in India.
  • Fee waivers for orphan drug trials will encourage more trials for rare diseases in India.

 

image_pdfMake PDF
Tags: GS-1Mains

Related Posts

World Bank’s Women, Business and the Law repot 2023

World Bank’s Women, Business and the Law repot 2023

March 7, 2023
The Parhaiyas of Jharkhand

The Parhaiyas of Jharkhand

February 17, 2023
Project ELLORA

Project ELLORA

February 2, 2023
Kuvi, Kui and Manda languages

Kuvi, Kui and Manda languages

January 31, 2023
Toto(Dengka) language

Toto(Dengka) language

January 28, 2023
Tribal Baiga art

Tribal Baiga art

January 27, 2023
Social Hostilities Index (SHI)

Social Hostilities Index (SHI)

December 6, 2022
The Tribal Development Report 2022

The Tribal Development Report 2022

December 1, 2022
Hindi imposition and its discontents

Hindi imposition and its discontents

November 5, 2022
Bonalu festival

Bonalu festival

November 5, 2022
Please login to join discussion

Our Offline Classroom Student

CONGRATULATIONS TO 2021 TOPPERS !!!

Rank 171 Kumar Shivashish
Rank 250 Sahithya
Rank 263 Sumit Kumar Thakur
Rank 311 Deepak Ramachandra Shet
Rank 455 Ravinandan B M

March 2023
MTWTFSS
 12345
6789101112
13141516171819
20212223242526
2728293031 
« Feb    

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tags

AIR All India Radio BBC Business Line Business Standard dow Down to Earth DownToEarth DTE Economic Times ET FAO Financial Express GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express Indiatoday India today Kurukshetra Livelihoods portal LiveMint Mains News Newspaper News Paper PIB Prelims PRS India RSTV Science Reporter Survey The Hindu The India Express The Indian Express The Print the wire Times of India TOI TOPPERS Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tag

AIR All India Radio BBC Business Line Business Standard dow Down to Earth DownToEarth DTE Economic Times ET FAO Financial Express GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express Indiatoday India today Kurukshetra Livelihoods portal LiveMint Mains News Newspaper News Paper PIB Prelims PRS India RSTV Science Reporter Survey The Hindu The India Express The Indian Express The Print the wire Times of India TOI TOPPERS Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In